SEC 13F Intelligence

Connor, Clark & Lunn Investment Management Ltd. / CRC

Connor, Clark & Lunn Investment Management Ltd.’s Canadian Nat Res Ltd Med Ter Position

Does Connor, Clark & Lunn Investment Management Ltd. own Canadian Nat Res Ltd Med Ter (CRC)? Yes — 6.75M shares worth $330M (+0.76% of its 13F portfolio) as of Q1 2026, up from 6.05M shares the prior filed quarter.

Position Value
$330M
Q1 2026
Shares
6.75M
% of Portfolio
+0.76%
Quarters Held
30
currently held

Position History CRC

Reported value by quarter
Q4 ’18: $112MQ4 ’18Q1 ’19: $137MQ2 ’19: $128MQ3 ’19: $104MQ4 ’19: $128MQ4 ’19Q1 ’20: $61MQ2 ’20: $110MQ3 ’20: $92MQ4 ’20: $124MQ4 ’20Q1 ’21: $141MQ2 ’21: $120MQ3 ’21: $115MQ4 ’21: $182MQ4 ’21Q1 ’22: $335MQ2 ’22: $247MQ3 ’22: $207MQ4 ’22: $246MQ4 ’22Q1 ’23: $275MQ2 ’23: $300MQ3 ’23: $457MQ4 ’23: $376MQ4 ’23Q1 ’24: $469MQ2 ’24: $431MQ3 ’24: $339MQ4 ’24: $414MQ4 ’24Q1 ’25: $330MQ2 ’25: $271MQ3 ’25: $307MQ4 ’25: $205MQ4 ’25Q1 ’26: $330Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20266.75M$330M+0.76%
Q4 20256.05M$205M+0.54%
Q3 20259.61M$307M+0.97%
Q2 20258.63M$271M+0.96%
Q1 202510.74M$330M+1.44%
Q4 202413.43M$414M+1.87%
Q3 202410.21M$339M+1.64%
Q2 202412.11M$431M+1.81%
Q1 20246.14M$469M+2.02%
Q4 20235.74M$376M+1.75%
Q3 20237.07M$457M+2.39%
Q2 20235.33M$300M+1.50%
Q1 20234.97M$275M+1.49%
Q4 20224.43M$246M+1.42%
Q3 20224.45M$207M+1.35%
Q2 20224.60M$247M+1.50%
Q1 20225.41M$335M+1.64%
Q4 20214.31M$182M+0.89%
Q3 20213.14M$115M+0.60%
Q2 20213.31M$120M+0.61%
Q1 20214.55M$141M+0.78%
Q4 20205.17M$124M+0.73%
Q3 20205.76M$92M+0.61%
Q2 20206.31M$110M+0.77%
Q1 20204.45M$61M+0.55%
Q4 20193.94M$128M+0.88%
Q3 20193.90M$104M+0.71%
Q2 20194.72M$128M+0.82%
Q1 20194.99M$137M+0.90%
Q4 20184.66M$112M+0.77%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Connor, Clark & Lunn Investment Management Ltd.’s full portfolio or all institutional holders of CRC.